Delia Silverio

446 total citations
10 papers, 301 citations indexed

About

Delia Silverio is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Delia Silverio has authored 10 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Cancer Research. Recurrent topics in Delia Silverio's work include Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Delia Silverio is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Delia Silverio collaborates with scholars based in United States, Greece and Austria. Delia Silverio's co-authors include Eliscer Guzman, Constantine E. Kosmas, Peter D. Montan, Andreas Sourlas, Mario J. García, Mario J. García and Gordon Mallarkey and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Translational Medicine and Patient Preference and Adherence.

In The Last Decade

Delia Silverio

10 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Delia Silverio United States 9 123 82 81 59 40 10 301
Svetlana Moșteoru Romania 6 199 1.6× 57 0.7× 49 0.6× 78 1.3× 59 1.5× 13 378
E Papakonstantinou Greece 8 133 1.1× 72 0.9× 38 0.5× 60 1.0× 49 1.2× 14 301
Maria Francesca Greco Italy 11 147 1.2× 39 0.5× 77 1.0× 52 0.9× 22 0.6× 18 283
Pablo Corral Argentina 8 154 1.3× 93 1.1× 52 0.6× 69 1.2× 20 0.5× 42 272
Joe L. Raya United States 9 161 1.3× 89 1.1× 82 1.0× 48 0.8× 69 1.7× 11 344
Yi‐Chih Lin Taiwan 7 77 0.6× 140 1.7× 119 1.5× 60 1.0× 64 1.6× 16 483
Bryant M. Whiting United States 7 71 0.6× 101 1.2× 109 1.3× 91 1.5× 57 1.4× 10 437
Paul J.W.H. Kappelle Netherlands 12 161 1.3× 158 1.9× 78 1.0× 65 1.1× 102 2.5× 15 393
Stephanie L. Hathaway Australia 1 276 2.2× 45 0.5× 130 1.6× 67 1.1× 65 1.6× 4 423
Nuntakorn Thongtang Thailand 9 188 1.5× 137 1.7× 41 0.5× 45 0.8× 37 0.9× 34 310

Countries citing papers authored by Delia Silverio

Since Specialization
Citations

This map shows the geographic impact of Delia Silverio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Delia Silverio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Delia Silverio more than expected).

Fields of papers citing papers by Delia Silverio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Delia Silverio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Delia Silverio. The network helps show where Delia Silverio may publish in the future.

Co-authorship network of co-authors of Delia Silverio

This figure shows the co-authorship network connecting the top 25 collaborators of Delia Silverio. A scholar is included among the top collaborators of Delia Silverio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Delia Silverio. Delia Silverio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kosmas, Constantine E., Delia Silverio, Andreas Sourlas, et al.. (2019). Anti-inflammatory therapy for cardiovascular disease. Annals of Translational Medicine. 7(7). 147–147. 49 indexed citations
2.
Montan, Peter D., et al.. (2019). Pharmacologic therapy of obesity: mechanisms of action and cardiometabolic effects. Annals of Translational Medicine. 7(16). 393–393. 40 indexed citations
3.
Kosmas, Constantine E., Delia Silverio, Andreas Sourlas, Peter D. Montan, & Eliscer Guzman. (2019). Dysfunctional high-density lipoprotein and atherogenesis. Vessel Plus. 2019. 6 indexed citations
4.
Kosmas, Constantine E., Andreas Sourlas, Gordon Mallarkey, et al.. (2019). Therapeutic management of hyperlipoproteinemia (a). Drugs in Context. 8. 1–11. 15 indexed citations
5.
Kosmas, Constantine E., et al.. (2018). Patient adherence, compliance, and perspectives on evolocumab for the management of resistant hypercholesterolemia. Patient Preference and Adherence. Volume 12. 2263–2266. 25 indexed citations
6.
Kosmas, Constantine E., et al.. (2018). Primary genetic disorders affecting high density lipoprotein (HDL). Drugs in Context. 7. 1–11. 11 indexed citations
7.
Kosmas, Constantine E., Delia Silverio, Andreas Sourlas, Peter D. Montan, & Eliscer Guzman. (2018). Role of spironolactone in the treatment of heart failure with preserved ejection fraction. Annals of Translational Medicine. 6(23). 461–461. 15 indexed citations
8.
Kosmas, Constantine E., et al.. (2018). Impact of lipid-lowering therapy on glycemic control and the risk for new-onset diabetes mellitus. Drugs in Context. 7. 1–7. 17 indexed citations
9.
Kosmas, Constantine E., et al.. (2018). Inclisiran: A New Promising Agent in the Management of Hypercholesterolemia. SHILAP Revista de lepidopterología. 6(3). 63–63. 74 indexed citations
10.
Kosmas, Constantine E., et al.. (2018). The Impact of Insulin Resistance and Chronic Kidney Disease on Inflammation and Cardiovascular Disease. Clinical Medicine Insights Endocrinology and Diabetes. 11. 3075455297–3075455297. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026